Skip to main content
. 2015 Jan 9;143(12):2570–2579. doi: 10.1017/S0950268814003355

Table 1.

Significant differences between group 1 (proven), group 2 (false-positive) and group 3 (unknown) subjects

Group 1 ‘proven cases’ (N = 466) Group 2 ‘false-positive cases’ (N = 103) Group 3 ‘unknown cases’ (N = 115)
Categorical variables* n (%) n (%) n (%) Significance tests
Age group Group 1 vs. 3
χ2 = 14·5, 5 d.f., P = 0·013
0–5 months 80 (17·2) 18 (17·5) 16 (13·9)
6–11 months 70 (15·0) 7 (6·8) 9 (7·8)
1–2 years 120 (25·8) 27 (26·2) 24 (20·9) Group 2 vs. 3
χ2 = 6·72, 5 d.f., P = 0·24
3–4 years 61 (13·1) 22 (21·4) 17 (14·8)
5–6 years 46 (9·9) 9 (8·7) 10 (8·7)
⩾7 years 89 (19·1) 20 (19·4) 39 (33·9)
Presenting hospital role Group 1 vs. 3
χ2 = 5·33, 2 d.f., P = 0·070
Paediatric specialist 221 (47·5) 17 (16·5) 54 (47·0)
Major hospital 140 (30·1) 12 (11·7) 25 (21·7)
District/other 104 (22·4) 74 (71·8) 36 (31·3) Group 2 vs. 3
χ2 = 36·43, 2 d.f., P < 0·0001
Presenting symptoms Group 1 vs. 3
χ2 = 50·58, 2 d.f., P < 0·0001
No meningitis/sepsis 41 (8·8) 53 (51·5) 39 (33·9)
Meningitis only present 176 (37·8) 12 (11·7) 25 (21·7)
Sepsis present 249 (53·4) 38 (36·9) 51 (44·4) Group 2 vs. 3
χ2 = 7·96, 2 d.f., P = 0·019
Year of admission Group 1 vs. 3
χ2 = 4·77, 7 d.f., P = 0·69
2000 54 (11·6) 6 (5·8) 19 (16·5)
2001 71 (15·3) 8 (7·8) 15 (13·0)
2002 91 (19·5) 10 (9·7) 20 (17·4) Group 2 vs. 3
χ2 = 20·96, 7 d.f., P = 0·0038
2003 67 (14·4) 17 (16·5) 12 (10·4)
2004 54 (11·6) 10 (9·7) 17 (14·8)
2005 47 (10·1) 16 (15·5) 14 (12·2)
2006 34 (7·3) 20 (19·4) 8 (7·0)
2007 48 (10·3) 16 (15·5) 10 (8·7)
Continuous variable* Mean (s.d.) Mean (s.d.) Mean (s.d.)
Total length of stay 8·3 days (11·8) 3·1 days (3·5) 5·1 days (5·7) Group 1 vs. 3
t = 4·25, P < 0·0001
Group 2 vs. 3
t = 3·17, P = 0·0018
Total time on mechanical ventilation 7·7 h (29·8) 1·3 h (7·6) 2·1 h (13·1) Group 1 vs. 3
t = 3·0, P = 0·0027
Group 2 vs. 3
t = 0·56, P = 0·58

Group 1 ‘proven’ cases: those notified as having meningococcal disease. May include subjects with single or multiple clinical records.

Group 2 ‘false-positive’ cases: non-notified subjects who had been discharged without a meningococcal diagnosis recorded on their final clinical record. Only includes subjects with multiple clinical records.

Group 3 ‘unknown’ cases: non-notified subjects who had been discharged with a meningococcal diagnosis on their final (or only) clinical record. May include subjects with either single or multiple clinical records.

*

Analysis of all categorical variables is based on the first hospital separation for the illness episode. Continuous variables are summed over all hospital separations in the illness episode.

One missing value in group 1.